Blood type A(B) is caused by a four gene mutations and was discovered when the blood of patients and donors was being studied ...

The first 100 bases of many genes show excess mutations, revealing a major genomic weak spot that shapes disease risk and ...

A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 ...

From extra digits to heightened senses, discover why science says some individuals are biologically extraordinary in a ...

A one millimeter worm is helping scientists rethink what controls the pace of aging. By tracing how its tiny brain senses the world and broadcasts hormonal commands, researchers are starting to see ...

Tap these Model Context Protocol servers to supercharge your AI-assisted coding tools with powerful devops automation ...

UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine (FFA) in children and adults with CDKL5 ...

KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

Sumitomo Pharma America, Inc. (SMPA) today presented new clinical data supporting further development of enzomenib, an investigational, oral selective menin inhibitor being researched for the ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...